Contribution of Baroreflex Afferent Pathway to NPY-Mediated Regulation of Blood Pressure in Rats.

Afferent Pathways Animals Baroreflex Blood Pressure Female Male Neuropeptide Y / physiology Rats Rats, Inbred SHR Receptors, Neuropeptide Y Sex Factors
Baroreflex Excitatory post-synaptic current Hypertension Neuropeptide Y Nucleus of the solitary tract

Journal

Neuroscience bulletin
ISSN: 1995-8218
Titre abrégé: Neurosci Bull
Pays: Singapore
ID NLM: 101256850

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 14 04 2019
accepted: 22 05 2019
pubmed: 30 10 2019
medline: 17 7 2021
entrez: 30 10 2019
Statut: ppublish

Résumé

Neuropeptide Y (NPY), a metabolism-related cardiovascular factor, plays a crucial role in blood pressure (BP) regulation via peripheral and central pathways. The expression of NPY receptors (Y

Identifiants

DOI: 10.1007/s12264-019-00438-w PMID: 31659606 PMC: PMC7142203
pubmed: 31659606
doi: 10.1007/s12264-019-00438-w
pii: 10.1007/s12264-019-00438-w
pmc: PMC7142203
doi:

Substances chimiques

Neuropeptide Y 0
Receptors, Neuropeptide Y 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-406

Références

Interdiscip Toxicol. 2014 Sep;7(3):159-64
pubmed: 26109894
Annu Rev Physiol. 2006;68:279-305
pubmed: 16460274
Sci Rep. 2016 Jul 08;6:29582
pubmed: 27387420
Neuron. 2000 Dec;28(3):927-39
pubmed: 11163277
Oncotarget. 2016 Oct 4;7(40):66135-66148
pubmed: 27623075
Eur J Neurosci. 2003 Feb;17(4):892-6
pubmed: 12603280
Regul Pept. 1986 Feb;13(3-4):307-18
pubmed: 3010387
Am J Physiol Cell Physiol. 2011 Jun;300(6):C1393-403
pubmed: 21325638
J Comp Neurol. 1996 Sep 23;373(3):309-21
pubmed: 8889930
Br J Pharmacol. 2012 Nov;167(5):1148-60
pubmed: 22708658
Diabetes. 2000 Feb;49(2):293-7
pubmed: 10868946
Annu Rev Physiol. 1994;56:93-116
pubmed: 7912060
Hypertension. 2005 Jan;45(1):9-14
pubmed: 15583075
J Neurosci. 2004 May 19;24(20):4709-17
pubmed: 15152030
Neuroscience. 2006;138(2):663-74
pubmed: 16387449
J Neuroendocrinol. 1999 Sep;11(9):715-23
pubmed: 10447810
Med Clin North Am. 2016 Jul;100(4):665-93
pubmed: 27235610
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Nov;33(11):1006-9
pubmed: 16563248
Hypertension. 2016 Aug;68(2):491-500
pubmed: 27296999
Mol Endocrinol. 1994 Oct;8(10):1298-308
pubmed: 7854347
Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E640-50
pubmed: 23321476
Curr Opin Pharmacol. 2003 Dec;3(6):613-7
pubmed: 14644013
J Neurosci. 1997 May 15;17(10):3425-35
pubmed: 9133368
Exp Physiol. 1991 May;76(3):369-77
pubmed: 1878194
Cell Physiol Biochem. 2018;45(1):88-107
pubmed: 29310113
Am J Cardiovasc Dis. 2011;1(1):48-59
pubmed: 22254185
J Neurophysiol. 1995 Feb;73(2):872-5
pubmed: 7760142
Nature. 1982 Apr 15;296(5858):659-60
pubmed: 6896083
Brain Res. 2002 Sep 6;948(1-2):145-8
pubmed: 12383966
Neurosci Bull. 2019 Feb;35(1):98-112
pubmed: 30146675
Neurosci Lett. 1992 Dec 14;148(1-2):169-72
pubmed: 1300491
Eur J Pharmacol. 2014 Oct 15;741:222-9
pubmed: 25179868
Physiol Res. 2016 Oct 24;65(Suppl 3):S309-S342
pubmed: 27775419
Hypertension. 2018 Jun;71(6):1248-1257
pubmed: 29686012
Trends Endocrinol Metab. 2015 Mar;26(3):125-35
pubmed: 25662369
Regul Pept. 2003 Jul 15;114(2-3):79-86
pubmed: 12832094
Can J Physiol Pharmacol. 2007 Jan;85(1):43-53
pubmed: 17487244
J Neurophysiol. 1992 Aug;68(2):509-17
pubmed: 1326604
J Pharmacol Exp Ther. 1997 Apr;281(1):291-6
pubmed: 9103509
Cell Physiol Biochem. 2015;37(3):1029-43
pubmed: 26402520
J Hypertens. 2016 Mar;34(3):464-73; discussion 473
pubmed: 26820476
Peptides. 1991 Jul-Aug;12(4):691-8
pubmed: 1664944

Auteurs

Yang Liu (Y)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.

Shu-Yang Zhao (SY)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Yan Feng (Y)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Jie Sun (J)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Xiao-Long Lu (XL)

Department of Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.

Qiu-Xin Yan (QX)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Ying Li (Y)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Zhuo Liu (Z)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
Riley Heart Center, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.

Lu-Qi Wang (LQ)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Xun Sun (X)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.

Shijun Li (S)

Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.

Guo-Fen Qiao (GF)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China. qiaogf88@163.com.

Bai-Yan Li (BY)

Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, 150081, China. liby@ems.hrbmu.edu.cn.
ORCID: 0000-0002-1853-0216

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Système nerveux › Voies nerveuses › Voies afférentes › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Eucaryotes › Animaux › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Réflexe › Baroréflexe › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Hémodynamique › Pression sanguine › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Neuropeptide Y › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Lignées consanguines de rats › Rats de lignée SHR › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur aux neuropeptides › Récepteur neuropeptide Y › Contribution of Baroreflex Afferent Pathway to...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Facteurs sexuels › Contribution of Baroreflex Afferent Pathway to...